Joint Formulary & PAD

Olanzapine - Agitation in palliative care

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Oro-dispersible
  • Tablets
Associated Icons :
BNF SPC
Un
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Olanzapine
Indication :
Agitation in palliative care
Group Name :
Keywords :
Brand Names Include :
Important Information :

Off-label use. On recommendation of palliative care team.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Olanzapine is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Agitation in palliative care.

  • No records returned.

Committee Recommendations (0)

  • No records returned.